- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01285869
Impact of a Multidimensional Intervention in Elderly Patients With Pneumonia (IMIEPAP)
Impact of a Multidimensional Intervention in Elderly Patients With Pneumonia: a Prospective Randomized Controlled Trial.
Study Overview
Status
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Barcelona, Spain, 08025
- Hospital de la Santa Creu i Sant Pau
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Elderly patients (aged 65 years and over), of either sex, not dependent for basic activities of daily living (Barthel index ≥60 points).
- Diagnosed with community-acquired pneumonia at the Emergency Department or Day Hospitals at "Hospital de la Santa Creu I Santa Pau"
- Admitted to hospital.
Exclusion Criteria:
- Derived from other acute care hospitals.
- Patients with HIV infection.
- Neutrophil counter<1000/mm3
- Transplanted patients.
- Barthel index<60 points.
- Terminal disease.
- No signed informed consent.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Multidisciplinar intervention
Patients that will receive the multidimensional intervention during the ambulatory follow-up.
|
The patient will be cited 2 months after hospital discharge for a geriatric evaluation carried out by a geriatric nurse and an internist with geriatric training.
The duration of the first visit is 45-60 minutes.
The visit consists of: 1. Assessment of the pneumonia resolution, co-morbidities, aspiration risk, risk of multiresistant infections, and the immunization, functional and cognitive status.
2.
An individualized intervention plan.
The patient and family or caregiver will receive an educational intervention, a written report with the planned intervention and an educational leaflet.
Those patients who require further assessment or follow up of the intervention will receive 1 or 2 more visits and all the patients will be cited one year after the first visit.
Other Names:
|
No Intervention: Conventional follow up
This is an observation only group and outpatient follow up will be indicated in accordance with usual and customary practices.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Healthcare resources utilization (readmissions and consultations to hospital and emergency department).
Time Frame: 1 year after hospital admission for pneumonia
|
To achieve the variables related to the healthcare resource utilization, computarized medical records will be reviewed and all patients will be followed up by telephone interview one year after discharge.The cause for readmission will be recorded.
|
1 year after hospital admission for pneumonia
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Functional status
Time Frame: 1 year after hospital admission for pneumonia
|
Data will be obtained by review of medical records and telephone interview one year after discharge. Dependency in basic activities of daily living will be scored using the Barthel Index (Mahoney & Barthel. Maryland State Med J 14; 61-65) which measures the capacity to perform ten basic activities and gives a quantitative estimation of the patient level of dependency, scoring to 0 (totally dependent) to 100 (totally independent). |
1 year after hospital admission for pneumonia
|
Institutionalization
Time Frame: 1 year after hospital admission for pneumonia
|
Data will be obtained by review of medical records and telephone interview one year after discharge.
|
1 year after hospital admission for pneumonia
|
Survival
Time Frame: 1 year after hospital admission for pneumonia
|
Data will be obtained by review of medical records and telephone interview to patient or relatives one year after discharge.
|
1 year after hospital admission for pneumonia
|
Collaborators and Investigators
Investigators
- Principal Investigator: Olga H Torres, Phd, Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- Study Chair: Domingo Ruiz, MD, Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IIBSP-INT-2010-13
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Community-acquired Pneumonia
-
GlaxoSmithKlineTerminated
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineTerminated
-
GlaxoSmithKlineCompleted
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
University Medical Centre LjubljanaUniversity of Ljubljana, Faculty of MedicineUnknownCommunity Acquired Pneumonia | Ventilator Associated Pneumonia | Hospital Acquired PneumoniaSlovenia
-
Basilea PharmaceuticaCompletedCommunity-acquired Pneumonia (CAP) | Hospital-acquired Pneumonia (HAP)Bulgaria, Hungary, Georgia, Romania
-
Liverpool University Hospitals NHS Foundation TrustLiverpool School of Tropical MedicineCompletedCommunity Acquired Pneumonia | Lower Respiratory Tract Infection | Hospital Acquired PneumoniaUnited Kingdom
-
Future University in EgyptRecruitingCommunity-acquired PneumoniaEgypt
-
Nordsjaellands HospitalRecruitingCommunity-acquired PneumoniaDenmark
Clinical Trials on Multidimensional intervention
-
Federal University of Minas GeraisMedical Research Council; University of Southampton; Federal University of the...Enrolling by invitationDiabetes Mellitus | Arterial HypertensionBrazil
-
Asia UniversityDepartment of Health, Executive Yuan, R.O.C. (Taiwan)Completed
-
Columbia UniversityNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingBlood PressureUnited States
-
Cairo UniversityMansoura University; Hiroshima UniversityCompletedStroke | Caregiver Burden | Caregiver BurnoutEgypt
-
University of TalcaNational Fund for Research and Development in Health, ChileNot yet recruiting
-
Qu ShenThe First Affiliated Hospital of Xiamen UniversityNot yet recruitingQuality of Life | Rehabilitation | Pilot Study | Colorectal Cancer Survivor
-
Norwegian Centre for Ageing and HealthThe Research Council of Norway; Kavli Research Center for Ageing and DementiaCompleted
-
Ithaca CollegeParkinson's FoundationCompletedParkinson DiseaseUnited States
-
Iran University of Medical SciencesCompletedLow Back Pain, MechanicalIran, Islamic Republic of
-
Institut für Pneumologie Hagen Ambrock eVActive, not recruitingOSA | COPD | COPD Exacerbation | CHFGermany